• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名20岁南亚患者的冠状动脉钙化——挑战“早期疾病”检测的极限。

Coronary artery calcium in a 20-year-old South Asian patient - pushing the limits of detecting "early disease".

作者信息

Tasdighi Erfan, Brumley Charlie, Vajramani Aashna, Blaha Michael J, Agarwala Anandita

机构信息

Johns Hopkins University, Baltimore, MD, United States.

Center for Cardiovascular Disease Prevention, Cardiovascular Division, Baylor Scott and White Health Heart Hospital Baylor Plano, Plano, TX, United States.

出版信息

Am J Prev Cardiol. 2025 Jan 22;21:100935. doi: 10.1016/j.ajpc.2025.100935. eCollection 2025 Mar.

DOI:10.1016/j.ajpc.2025.100935
PMID:40201144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11977114/
Abstract

Coronary artery calcium (CAC) assessment has long been reserved for intermediate-risk individuals in mid- to older-adult populations. However, a growing body of evidence supports expanding CAC measurement to younger adults who exhibit multiple risk factors or other risk-enhancing features. We describe a case of a very young, 20-year-old, South Asian man with a CAC score of 15.7 Agatston Units. Despite his age and lack of overt symptoms, his CAC score placed him at the 99th percentile for his age and sex, underscoring the limitations of relying solely on traditional risk algorithms. Early CAC detection in such patients has potential for significant clinical impact, allowing timely implementation of intensive lifestyle modification and the most aggressive possible pharmacotherapy for cardiovascular risk reduction. Evidence indicates that even minimal CAC in very young individuals can progress exponentially, markedly increasing the risk of future atherosclerotic cardiovascular disease. Nonetheless, current guidelines do not recommend CAC testing in this population, creating a missed opportunity to detect and intervene in high-risk individuals during early adulthood. These observations underscore the need for more precise risk stratification strategies in select high-risk populations. Incorporating CAC measurements into care for young, high-risk individuals-alongside newer tools such as polygenic risk scores and low-radiation coronary CT angiography-could revolutionize preventive cardiology. Further research is needed to refine the cost-effectiveness and implementation strategies for early CAC measurement, develop more inclusive guidelines, and ensure a specialized workforce capable of delivering comprehensive preventive care.

摘要

冠状动脉钙化(CAC)评估长期以来一直局限于中老年人群中的中危个体。然而,越来越多的证据支持将CAC检测扩展至具有多种危险因素或其他风险增强特征的年轻成年人。我们描述了一例非常年轻的20岁南亚男性病例,其CAC评分为15.7阿加斯顿单位。尽管他年龄小且没有明显症状,但他的CAC评分在其年龄和性别的人群中处于第99百分位,这凸显了仅依靠传统风险算法的局限性。在此类患者中早期检测CAC有可能产生重大临床影响,能够及时实施强化生活方式改变以及采取最积极的药物治疗以降低心血管风险。有证据表明,即使是非常年轻个体中的微量CAC也可能呈指数级进展,显著增加未来发生动脉粥样硬化性心血管疾病的风险。尽管如此,当前指南并不推荐对此类人群进行CAC检测,从而错失了在成年早期检测并干预高危个体的机会。这些观察结果强调了在特定高危人群中需要更精确的风险分层策略。将CAC检测纳入年轻高危个体的护理中,再结合多基因风险评分和低辐射冠状动脉CT血管造影等新工具,可能会彻底改变预防心脏病学。需要进一步研究以完善早期CAC检测的成本效益和实施策略,制定更具包容性的指南,并确保有一支能够提供全面预防护理的专业队伍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f774/11977114/282429177edf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f774/11977114/282429177edf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f774/11977114/282429177edf/gr1.jpg

相似文献

1
Coronary artery calcium in a 20-year-old South Asian patient - pushing the limits of detecting "early disease".一名20岁南亚患者的冠状动脉钙化——挑战“早期疾病”检测的极限。
Am J Prev Cardiol. 2025 Jan 22;21:100935. doi: 10.1016/j.ajpc.2025.100935. eCollection 2025 Mar.
2
Implications of the 2019 American College of Cardiology/American Heart Association Primary Prevention Guidelines and potential value of the coronary artery calcium score among South Asians in the US: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) study.2019 年美国心脏病学会/美国心脏协会一级预防指南的意义,以及在美国南亚人群中冠状动脉钙评分的潜在价值:生活在美国的南亚人中动脉粥样硬化的介质(MASALA)研究。
Atherosclerosis. 2021 Oct;334:48-56. doi: 10.1016/j.atherosclerosis.2021.08.030. Epub 2021 Aug 23.
3
Personalization of primary prevention: Exploring the role of coronary artery calcium and polygenic risk score in cardiovascular diseases.一级预防的个性化:探索冠状动脉钙化和多基因风险评分在心血管疾病中的作用。
Trends Cardiovasc Med. 2025 Apr;35(3):154-163. doi: 10.1016/j.tcm.2024.10.003. Epub 2024 Oct 21.
4
Cardiac Society of Australia and New Zealand Position Statement: Coronary Artery Calcium Scoring.澳大利亚和新西兰心脏学会立场声明:冠状动脉钙化评分
Heart Lung Circ. 2017 Dec;26(12):1239-1251. doi: 10.1016/j.hlc.2017.05.130. Epub 2017 Jun 16.
5
Distribution of Coronary Artery Calcium by Age, Sex, and Race Among Patients 30-45 Years Old.30-45 岁患者的冠状动脉钙分布按年龄、性别和种族划分。
J Am Coll Cardiol. 2022 May 17;79(19):1873-1886. doi: 10.1016/j.jacc.2022.02.051.
6
Polygenic Risk Scores and Extreme Coronary Artery Calcium Phenotypes (CAC=0 and CAC≥1000) in Adults ≥75 Years Old: The ARIC Study.多基因风险评分与≥75 岁成年人的极重度冠状动脉钙表型(CAC=0 和 CAC≥1000):ARIC 研究。
Circ Cardiovasc Imaging. 2024 Nov;17(11):e016377. doi: 10.1161/CIRCIMAGING.123.016377. Epub 2024 Nov 13.
7
The Future of Concurrent Automated Coronary Artery Calcium Scoring on Screening Low-Dose Computed Tomography.低剂量计算机断层扫描筛查中同步自动冠状动脉钙化评分的未来
Cureus. 2020 Jun 12;12(6):e8574. doi: 10.7759/cureus.8574.
8
Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals.当代他汀类药物使用指南在非裔美国人中联合或不联合冠状动脉钙化评估的成本效益
JAMA Cardiol. 2020 Aug 1;5(8):871-880. doi: 10.1001/jamacardio.2020.1240.
9
Expert review on coronary calcium.冠状动脉钙化专家综述
Vasc Health Risk Manag. 2008;4(2):315-24. doi: 10.2147/vhrm.s1160.
10
Defining Demographic-specific Coronary Artery Calcium Percentiles in the Population Aged ≥75: The ARIC Study and MESA.定义≥75 岁人群中特定人群的冠状动脉钙百分比:ARIC 研究和 MESA。
Circ Cardiovasc Imaging. 2023 Sep;16(9):e015145. doi: 10.1161/CIRCIMAGING.122.015145. Epub 2023 Sep 1.

本文引用的文献

1
Allocation of Semaglutide According to Coronary Artery Calcium and BMI: Applying the SELECT Trial to MESA.根据冠状动脉钙化和体重指数分配司美格鲁肽:将SELECT试验应用于多族裔动脉粥样硬化研究(MESA)
JACC Cardiovasc Imaging. 2025 Apr;18(4):451-461. doi: 10.1016/j.jcmg.2024.10.004. Epub 2025 Jan 8.
2
Coronary Artery Calcium Staging to Guide Preventive Interventions: A Proposal and Call to Action.冠状动脉钙化分期以指导预防性干预:一项提议与行动呼吁。
JACC Adv. 2024 Sep 24;3(11):101287. doi: 10.1016/j.jacadv.2024.101287. eCollection 2024 Nov.
3
Standards for quantitative assessments by coronary computed tomography angiography (CCTA): An expert consensus document of the society of cardiovascular computed tomography (SCCT).
冠状动脉计算机断层扫描血管造影(CCTA)定量评估标准:心血管计算机断层扫描学会(SCCT)专家共识文件。
J Cardiovasc Comput Tomogr. 2024 Sep-Oct;18(5):429-443. doi: 10.1016/j.jcct.2024.05.232. Epub 2024 Jun 6.
4
Identification and Management of Atherosclerotic Cardiovascular Disease Risk in South Asian Populations in the U.S.美国南亚人群动脉粥样硬化性心血管疾病风险的识别与管理
JACC Adv. 2023 Mar;2(2). doi: 10.1016/j.jacadv.2023.100258. Epub 2023 Mar 31.
5
Subclinical atherosclerosis on chest computed tomography and mortality in young patients with severe hypercholesterolemia.胸部计算机断层扫描显示的亚临床动脉粥样硬化与重度高胆固醇血症年轻患者的死亡率
Prog Cardiovasc Dis. 2023 Nov-Dec;81:105-108. doi: 10.1016/j.pcad.2023.11.002. Epub 2023 Nov 4.
6
Assessment of cardiovascular disease risk: a 2023 update.心血管疾病风险评估:2023 年更新。
Curr Opin Lipidol. 2023 Aug 1;34(4):162-173. doi: 10.1097/MOL.0000000000000887. Epub 2023 May 15.
7
The use of coronary artery calcium scoring in young adults.冠状动脉钙评分在年轻成年人中的应用。
J Cardiovasc Comput Tomogr. 2023 Jul-Aug;17(4):242-247. doi: 10.1016/j.jcct.2023.04.004. Epub 2023 May 15.
8
Effects of lifestyle interventions on cardiovascular risk factors in South Asians: a systematic review and meta-analysis.生活方式干预对南亚人心血管危险因素的影响:系统评价和荟萃分析。
BMJ Open. 2022 Dec 9;12(12):e059666. doi: 10.1136/bmjopen-2021-059666.
9
Once-Weekly Semaglutide in Adolescents with Obesity.每周一次司美格鲁肽治疗肥胖青少年。
N Engl J Med. 2022 Dec 15;387(24):2245-2257. doi: 10.1056/NEJMoa2208601. Epub 2022 Nov 2.
10
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee.2022年美国心脏病学会解决方案集监督委员会关于非他汀类疗法在降低低密度脂蛋白胆固醇以管理动脉粥样硬化性心血管疾病风险中的作用的专家共识决策路径报告。
J Am Coll Cardiol. 2022 Oct 4;80(14):1366-1418. doi: 10.1016/j.jacc.2022.07.006. Epub 2022 Aug 25.